Newsletter | January 31, 2022

01.31.22 -- Managing The Biomanufacturing Supply Chain

 
Security Of Supply In Cell And Gene Therapy Manufacturing
 

With so many challenges involved in the manufacturing of cell and gene therapies, building an adequate supply chain with the necessary equipment and protocols is critical for companies pursuing these life-saving drugs.

Cytiva Attains Business Continuity Management System ISO Certification
 

The new ISO 22301:2019 certification covers methods and procedures for maintaining emergency response, crisis management, and business continuity capabilities, including communication, implementation, and continual improvement.

Behind The Scenes: Downstream Hardware Equipment Manufacturing In Umeå
 

Take a short virtual tour of Cytiva’s downstream hardware manufacturing site in Umeå, Sweden, to see how iconic Biacore™, AxiChrom™, and ÄKTA™ products are crafted. Our experienced staff, high-quality components, and validated production processes play an important role in helping our customers achieve their results.

How Customer Forecasts Support The Integrity Of The Biopharma Supply Chain
 
Receiving customer forecasts as early and completely as possible is critical to the success of the supply chain continuum.
Security Of Supply For Critical Reagents Used In HCP Analysis
 
For reagents, security of supply is a regulatory requirement, a factor that’s critical to consistently monitoring host cell protein (HCP) during the production of a biologic.
Latest News On Cytiva Capacity Expansion And Acquisitions